ISO 14971 is die internationale Norm für die Anwendung von Risikomanagement auf Medizinprodukte.
Complete Guide to ISO 14971
ISO 14971:2019 is the internationally recognized standard that specifies a process for manufacturers to identify hazards associated with medical devices, estimate and evaluate the associated risks, control these risks, and monitor the effectiveness of controls.
Key features of ISO 14971:
- Latest version: ISO 14971:2019 (published December 2019)
- Harmonized standard under EU MDR and IVDR
- Recognized by FDA and global regulators
- Lifecycle approach to risk management
- Risk-benefit analysis framework
Risk management process:
1. Risk Analysis
- Identify intended use and reasonably foreseeable misuse
- Identify hazards and hazardous situations
- Estimate risks for each hazardous situation
2. Risk Evaluation
- Compare estimated risks against risk acceptability criteria
- Determine if risk reduction is required
- Risk-benefit analysis for residual risks
3. Risk Control
- Implement risk control measures (inherent safety, protective measures, information)
- Verify effectiveness of risk controls
- Assess any new risks introduced by control measures
4. Production and Post-Production
- Collect and review information from production and post-market
- Update risk management file
- Trend analysis and feedback loop
Integration with FMEA:
- Failure Mode and Effects Analysis (FMEA) commonly used
- Risk Priority Number (RPN) calculation
- Design FMEA (DFMEA) and Process FMEA (PFMEA)
- Complements ISO 14971 systematic approach
Residual risk evaluation:
- All risks cannot be eliminated
- Residual risks must be evaluated for acceptability
- Risk-benefit analysis required
- Must be disclosed in labeling/instructions for use
Relationship to regulations:
- EU MDR/IVDR: Annex I requires compliance with ISO 14971
- FDA: Recognized consensus standard (guidance documents reference it)
- ISO 13485: Risk management integrated throughout QMS
- IEC 62304: Software risk management requirements
Risk management file:
- Living document updated throughout product lifecycle
- Contains risk analysis, evaluation, control, and monitoring
- Required for regulatory submissions (510(k), CE marking)
- Subject to audits and inspections
Related Terms
More Compliance & Standards
View allDie Qualitätssystemverordnung der FDA, die cGMP-Anforderungen (current Good Manufacturing Practice) für Medizinproduktehersteller in den USA festlegt.
Eine systematische, unabhängige Prüfung eines Qualitätsmanagementsystems, um festzustellen, ob Qualitätsaktivitäten und -ergebnisse den geplanten Vereinbarungen entsprechen und ob diese Vereinbarungen wirksam umgesetzt werden.
Ein systematischer Ansatz zur Untersuchung, Korrektur und Verhinderung von Qualitätsproblemen in der Medizinproduktherstellung und im Betrieb.
Eine obligatorische Konformitätskennzeichnung für im Europäischen Wirtschaftsraum verkaufte Medizinprodukte, die die Einhaltung der EU-Gesundheits-, Sicherheits- und Umweltschutzanforderungen anzeigt.
Need Help with Global Registration?
Pure Global provides regulatory consulting and AI-powered tools to help medical device companies navigate Global market access.

